7065-18-1

Basic information

• Product Name: 1-butyl-5-{[3-(3-ethoxypropyl)-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-6-[4-(4-fluorophenyl)piperazin-1-yl]-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
• CAS NO: 7065-18-1
• Molecular Formula: C₁₂H₁₀AsI
• Molecular Weight: 597.7669
• Mol File: 7065-18-1.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 611.6°C at 760 mmHg
• Flash Point: 323.7°C
• Density: 1.34g/cm³
• Vapor Pressure: 6.73E-15mmHg at 25°C
• Refractive Index: 1.653
• CAS DataBase Reference: 1-butyl-5-{[3-(3-ethoxypropyl)-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-6-[4-(4-fluorophenyl)piperazin-1-yl]-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 1-butyl-5-{[3-(3-ethoxypropyl)-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-6-[4-(4-fluorophenyl)piperazin-1-yl]-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile(7065-18-1)
• EPA Substance Registry System: 1-butyl-5-{[3-(3-ethoxypropyl)-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-6-[4-(4-fluorophenyl)piperazin-1-yl]-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile(7065-18-1)

Safety Data

• Hazardous Substances Data: 7065-18-1(Hazardous Substances Data)

Usage

Thiazolidine ring

A five-membered ring containing a sulfur atom and a nitrogen atom.

Piperazine ring

A six-membered ring containing two nitrogen atoms.

Dihydropyridine ring

A six-membered ring with two nitrogen atoms and one double bond, which is partially saturated.

Carbonitrile group

A cyano group (C≡N) attached to a carbon atom.

Butyl group

A four-carbon alkyl chain (-CH2CH2CH2CH3) attached to the molecule.

Ethoxypropyl group

An ethoxy (-OCH2CH3) group attached to a propyl (-CH2CH2CH3) chain.

Fluorophenyl group

A phenyl group (C6H5) with one hydrogen atom replaced by a fluorine atom.

Oxo group

A double-bonded oxygen atom (=O) present in the molecule.

Sulfur atom

A sulfur atom present in the thiazolidine ring.

Nitrogen atoms

Multiple nitrogen atoms present in the thiazolidine, piperazine, and dihydropyridine rings.

Potential pharmaceutical activity

The presence of various functional groups suggests possible applications as an antihypertensive or antidiabetic agent.

Further research needed

To determine the specific physiological effects and potential applications of this chemical.

Upstream product

• 603-32-7 triphenyl-arsane 
• 6380-34-3 phenyldiiodoarsine 
• 829-83-4 diphenylarsane 
• 712-48-1 chlorodiphenylarsine 
• 2215-16-9 bis(diphenylarsino)oxide 
• 74-88-4 methyl iodide 
• 3095-87-2 bromodiphenylarsine 
• 2215-36-3 tetraphenyl-diarsane 
• 861788-47-8 diphenyl-thiocyanato-arsine 
• 17544-92-2 propyl diphenylarsinothioate 
• 55843-74-8 phenyltellurenyl iodide 
• 153921-22-3 Se-diphenylarsanyl 4-methylbenzenecarboselenoate 
• 110837-99-5 As,As,N-triphenylarsinous amide 
• 41006-64-8 Natrium-diphenylarsenid 

Downstream Products

• 2215-36-3 tetraphenyl-diarsane 
• 2647-46-3 Heptafluorpropyl-diphenylarsin 
• 2215-16-9 bis(diphenylarsino)oxide 
• 74096-94-9 [C₆H₅Cr(CO)3]As(C₆H₅)2 

Relevant articles and documents

Diphenylarsenic(III) Iodide

AsPh2I (iododiphenylarsine) contains arsenic in trigonal pyramidal coordination with iodine and two phenyl groups, with effectively equal As-C distances .Bond angles at arsenic are 101.7 (2) deg between the phenyl groups

Oral administration of diphenylarsinic acid, a degradation product of chemical warfare agents, induces oxidative and nitrosative stress in cerebellar Purkinje cells

A new clinical syndrome with prominent cerebellar symptoms in patients living in Kamisu City, Ibaraki Prefecture, Japan, is described. Since the patients ingested drinking water containing diphenylarsinic acid (DPA), a stable degradation product of both diphenylcyanoarsine and diphenylchloroarsine, which were developed for use as chemical weapons and cause severe vomiting and sneezing, DPA was suspected of being responsible for the clinical syndrome. The purpose of the present study was to elucidate prominent cerebellar symptoms due to DPA. The aim of the study was to determine if single (15 mg/kg) or continuous (5 mg/kg/day for 5 weeks) oral administration of DPA to ICR-strain mice induced oxidative and/or nitrosative stress in their brain. Significantly positive staining with malondialdehyde (MDA) and 3-nitrotyrosine (3-NT) was observed in the cerebellar Purkinje cells by repeated administration (5 mg/kg/day) with DPA for 5 weeks that led to the cerebellar symptoms from a behavioral pharmacology standpoint and by single administration of DPA (15 mg/kg). Furthermore, it is possible that the production of 3-NT was not caused by peroxynitrite formation. The present results suggest the possibility that arsenic-associated novel active species may be a factor underlying the oxidative and nitrosative stress in Purkinje cells due to exposure to DPA, and that the damage may lead to the cerebellar symptoms.

Synthesis and characterization of Se-organoarsanyl selenocarboxylates

Sodium selenocarboxylates were found to react with organoarsanyl chlorides Ph3-(n)AsCl(n) 1-3 (n = 1, 2, 3) to give the corresponding Se-organoarsanyl esters RCOSeAsPh2 (5), (RCOSe)2AsPh (6) and (RCOSe)3As (7) in good yields. The reaction of Se-diphenylarsanyl 4-methylbenzenecarboselenoate 5g with phenylselenenyl bromide and phenyltellurenyl iodide afforded the corresponding Se-phenyl-selenenyl 13 and Se-phenyltellurenyl esters 14 in moderate yields, while the reaction with sodium phenoxide gave sodium 4- methylbenzenecarboselenoate (4g), phenyl 4-methylbenzoate (11) and phenoxydiphenylarsine (12), indicating the attack of phenoxy anion to both the carbonyl carbon and arsenic atoms.